Generation of HIV Latency in Humanized BLT Mice

被引:156
作者
Denton, Paul W. [1 ]
Olesen, Rikke [1 ,4 ]
Choudhary, Shailesh K. [1 ]
Archin, Nancy M. [1 ]
Wahl, Angela [1 ]
Swanson, Michael D. [1 ]
Chateau, Morgan [1 ]
Nochi, Tomonori [1 ]
Krisko, John F. [1 ]
Spagnuolo, Rae Ann [1 ]
Margolis, David M. [1 ,2 ,3 ]
Garcia, J. Victor [1 ]
机构
[1] Univ N Carolina, Dept Internal Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[4] Aarhus Univ Hosp, Dept Infect Dis, Sheiby, Denmark
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL RESERVOIRS; IMMUNE-ACTIVATION; PLASMA VIREMIA; VALPROIC ACID; T-CELLS; INFECTION; MODEL; TRANSMISSION;
D O I
10.1128/JVI.06120-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Here we demonstrate that a combination of tenofovir, emtricitabine, and raltegravir effectively suppresses peripheral and systemic HIV replication in humanized BLT mice. We also demonstrate that antiretroviral therapy (ART)-treated humanized BLT mice harbor latently infected resting human CD4(+) T cells that can be induced ex vivo to produce HIV. We observed that the levels of infected resting human CD4(+) T cells present in BLT mice are within the range of those observed circulating in patients undergoing suppressive ART. These results demonstrate the potential of humanized BLT mice as an attractive model for testing the in vivo efficacy of novel HIV eradication strategies.
引用
收藏
页码:630 / 634
页数:5
相关论文
共 39 条
  • [1] Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
    Archin, Nancy M.
    Eron, Joseph J.
    Palmer, Sarah
    Hartmann-Duff, Anne
    Martinson, Jeffery A.
    Wiegand, Ann
    Bandarenko, Nicholas
    Schmitz, John L.
    Bosch, Ronald J.
    Landay, Alan L.
    Coffin, John M.
    Margolis, David M.
    [J]. AIDS, 2008, 22 (10) : 1131 - 1135
  • [2] Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
    Blankson, JN
    Finzi, D
    Pierson, TC
    Sabundayo, BP
    Chadwick, K
    Margolick, JB
    Quinn, TC
    Siliciano, RF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1636 - 1642
  • [3] Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice
    Brainard, Diana M.
    Seung, Edward
    Frahm, Nicole
    Cariappa, Annaiah
    Bailey, Charles C.
    Hart, William K.
    Shin, Hae-Sook
    Brooks, Sarah F.
    Knight, Heather L.
    Eichbaum, Quentin
    Yang, Yong-Guang
    Sykes, Megan
    Walker, Bruce D.
    Freeman, Gordon J.
    Pillai, Shiv
    Westmoreland, Susan V.
    Brander, Christian
    Luster, Andrew D.
    Tager, Andrew M.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (14) : 7305 - 7321
  • [4] Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
    Choudhary, Shailesh K.
    Margolis, David M.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011, 2011, 51 : 397 - 418
  • [5] Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
    Chun, Tae-Wook
    Nickle, David C.
    Justement, Jesse S.
    Meyers, Jennifer H.
    Roby, Gregg
    Hallahan, Claire W.
    Kottilil, Shyam
    Moir, Susan
    Mican, Joann M.
    Mullins, James I.
    Ward, Douglas J.
    Kovacs, Joseph A.
    Mannon, Peter J.
    Fauci, Anthony S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05) : 714 - 720
  • [6] Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
    Chun, Tae-Wook
    Justement, J. Shawn
    Murray, Danielle
    Hallahan, Claire W.
    Maenza, Janine
    Collier, Ann C.
    Sheth, Prameet M.
    Kaul, Rupert
    Ostrowski, Mario
    Moir, Susan
    Kovacs, Colin
    Fauci, Anthony S.
    [J]. AIDS, 2010, 24 (18) : 2803 - 2808
  • [7] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection
    Chun, TW
    Carruth, L
    Finzi, D
    Shen, XF
    DiGiuseppe, JA
    Taylor, H
    Hermankova, M
    Chadwick, K
    Margolick, J
    Quinn, TC
    Kuo, YH
    Brookmeyer, R
    Zeiger, MA
    BarditchCrovo, P
    Siliciano, RF
    [J]. NATURE, 1997, 387 (6629) : 183 - 188
  • [8] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
    Chun, TW
    Stuyver, L
    Mizell, SB
    Ehler, LA
    Mican, JAM
    Baseler, M
    Lloyd, AL
    Nowak, MA
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197
  • [9] Simian immunodeficiency virus macaque models of HIV latency
    Deere, Jesse D.
    Schinazi, Raymond F.
    North, Thomas W.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (01) : 57 - 61
  • [10] One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
    Denton, Paul W.
    Othieno, Florence
    Martinez-Torres, Francisco
    Zou, Wei
    Krisko, John F.
    Fleming, Elisa
    Zein, Sima
    Powell, Daniel A.
    Wahl, Angela
    Kwak, Youn Tae
    Welch, Brett D.
    Kay, Michael S.
    Payne, Deborah A.
    Gallay, Philippe
    Appella, Ettore
    Estes, Jacob D.
    Lu, Min
    Garcia, J. Victor
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (15) : 7582 - 7593